BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
RIDGEFIELD, CT

Boehringer Ingelheim Pharmaceuticals, Inc., incorporated on July 25, 2003, is a globally recognized research-driven pharmaceutical company headquartered in Ridgefield, CT. Despite its home state being registered as Delaware, the company's mailing address is located at 900 Ridgebury Road, Ridgefield, Connecticut (zipcode: 06877). Known for embracing diverse cultures and societies worldwide, Boehringer Ingelheim operates under the For-Profit Corporation status with a Filed Number of F03000003710. The organization prides itself on advancing health through innovative pharmaceutical solutions, aiming to significantly enhance patient lives. The company maintains transparent relations with its stakeholders by actively facilitating adverse event reporting compliant with respective country protocols through their official channels at boehringeringelheimpharmaceuticals.com. Recent officers and directors include Christian Orth in the capacity of Senior and Director roles, as well as Paula Esq. Wittmayer serving as Assistant, underscoring the company's commitment to leadership excellence. Official contact numbers include (178) 290-5056; (178) 290-4900; (178) 290-8178; (178) 290-8561; (203) 798-5564; and (914) 548-4061. With the Federal Employer Identification Number (FEI) of 13-2686668, Boehringer Ingelheim Pharmaceuticals' operations continue robustly with its latest Annual Report published on April 15, 2024. The company warmly invites individuals to connect with their Corporate & Product Public Relations Team and join them in making significant contributions towards improving global health.